Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

» XBI's 10-Y Financials


» Details

Insider Trades

Latest Guru Trades with XBI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )



Valuation & Return


More Statistics

Short Percentage of Float0.00%
52-Week Range $0.01 - 271.07

Business Description

Industry: »
Compare:0 » details
» More Articles for XBI


Articles On GuruFocus.com
Yacktman Fund Comments on Staples Feb 05 2016 
Yacktman Fund Comments on Apollo Feb 05 2016 
Yacktman Fund Comments on C.H. Robinson Feb 05 2016 
Yacktman Fund Comments on PepsiCo Feb 05 2016 
Yacktman Fund Comments on P&G Feb 05 2016 
Yacktman Fund Comments on Microsoft Feb 05 2016 
Auxier Asset Management Year-End 2015 Market Commentary Feb 05 2016 
On Running a Concentrated Portfolio Feb 05 2016 
Mario Gabelli Comments on Rolls-Royce Holding plc Feb 05 2016 
Mario Gabelli Comments on Legg Mason Inc. Feb 05 2016 

More From Other Websites
[$$] Celgene and Gilead: Two Drugmakers, 30% Upside Feb 06 2016
Some biotechnology stocks that provide ‘clear opportunities,’ J.P. Morgan says Feb 05 2016
ETFs to Play a Pop in Biotech M&A Feb 05 2016
10:31 am Biotech stocks (XBI) up 4.5% after reversing yesterday Feb 04 2016
TickerTags Data Shows Drug Price Debate Still Trending Feb 03 2016
3 Biotech ETFs With Bear-Killing Magic Feb 03 2016
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, ALPS... Feb 02 2016
Tracking The Biotech Bubble's Bust Jan 31 2016
If history rhymes this indicator suggests stocks still have a long way to fall Jan 29 2016
The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Bullish Fund, SPDR S&P Biotech ETF, SPDR... Jan 29 2016
ETF Winners & Losers Post Fed Meet Jan 28 2016
Revlimid Continues to Drive Celgene’s Revenue Jan 22 2016
Even With Volatility, Investors Love Biotech ETFs Jan 22 2016
Calls bet on quick pop in biotech fund Jan 19 2016
Bloodied Biotech Stocks Had It Coming, But Check Out This Chart Jan 18 2016
Is it time to bet on biotech? Jan 14 2016
Investor Apathy Keeps Biotech Stocks in the Red Jan 13 2016
Tuesday links: commodity fundamentals Jan 12 2016
Betting On A Biotech Bounce With A Familiar ETF Jan 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)